Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nutex HealthFRA:5LF +3.77%57 ROC (Joel Greenblatt) % is 82.77% as of Jun. 2026, which is 139% above its 10-year median of 34.60. GuruFocus rates FRA:5LF with a GF Score™ of 57/100 and a GF Value™ of €70.29 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 674 Healthcare Providers & Services companies, Nutex Health ranks better than 83.98% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Nutex Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 82.77%.
The historical rank and industry rank for Nutex Health's ROC (Joel Greenblatt) % or its related term are showing as below:
FRA:5LF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -123.98 Med: 34.6 Max: 70.73
Current: 63.02
During the past 7 years, Nutex Health's highest ROC (Joel Greenblatt) % was 70.73%. The lowest was -123.98%. And the median was 34.60%.
FRA:5LF's ROC (Joel Greenblatt) % is ranked better than 83.98% of 674
companies
in the Healthcare Providers & Services industry
Industry Median: 12.5
vs FRA:5LF: 63.02
Nutex Health's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
Nutex Health (FRA:5LF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Nutex Health ROC (Joel Greenblatt) % Related Terms
Nutex Health ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Nutex Health's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5LF vs USPH, AMN, GMRS: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Nutex Health's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutex Health ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Nutex Health's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 82.77% mean?
Nutex Health (FRA:5LF) has a ROC (Joel Greenblatt) % of 82.77% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Nutex Health and its competitors. This is 139% above median its historical median of 34.60. According to the industry distribution chart, Nutex Health ranks #108 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 16%.
Is Nutex Health's ROC (Joel Greenblatt) % too high?
Nutex Health's current ROC (Joel Greenblatt) % of 82.77% is 139% above median its 10-year median of 34.60. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.50. Nutex Health's value of 82.77% is 562.2% above this industry median. Based on the distribution chart, Nutex Health ranks #108 out of 674 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nutex Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's ROC (Joel Greenblatt) % compare to USPH and AMN?
According to the Healthcare Providers & Services industry distribution chart, Nutex Health ranks #108 out of 674 companies for ROC (Joel Greenblatt) %. This places Nutex Health in the top 16% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.50. Nutex Health's value of 82.77% is 562.2% above this benchmark. While the company's 10-year median is 34.60 vs. the industry median of 12.50, Nutex Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.50, based on 674 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutex Health's current ROC (Joel Greenblatt) % of 82.77% is 562.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Nutex Health and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutex Health's current ROC (Joel Greenblatt) % is 82.77%, which is 139% above median its own 10-year median of 34.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (FRA:5LF) is currently considered Significantly Overvalued. The stock's GF Value™ is €70.29, compared to a current price of €165.00 — trading 134.7% above its estimated fair value. The current ROC (Joel Greenblatt) % is 82.77%, which is 139% above median its 10-year median of 34.60 and 562.2% above the Healthcare Providers & Services industry median of 12.50. Nutex Health's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Nutex Health (FRA:5LF), the current ROC (Joel Greenblatt) % is 82.77% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutex Health (FRA:5LF) Overvalued in 2026?
Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued.
The current stock price of €165.00 is trading 134.7% above its estimated GF Value™ of €70.29.
GuruFocus considers Nutex Health to be Significantly Overvalued.
Key valuation signals for FRA:5LF:
ROC (Joel Greenblatt) %: 82.77% (139% above median its 10-year median of 34.60)
GF Value™: €70.29 vs. price of €165.00 (134.7% above fair value)
Industry Position: 562.2% above the Healthcare Providers & Services median (#108 of 674)
No single metric tells the full story. See the FRA:5LF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
57GF Score
Get the complete analysis for FRA:5LF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5LF has been successfully added to your 
